Which is better, PAHC or PME.AX?

On the Buffett-Fit framework, Pro Medicus Limited (PME.AX) currently grades higher than PAHC — 78/100 (B grade) vs 43/100 (D). That said, "better" depends on which framework you trust — PAHC wins on none; PME.AX wins on Warren Buffett, Benjamin Graham, Philip Fisher, Peter Lynch, Joel Greenblatt, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy PAHC or PME.AX?

This page is an educational comparison, not investment advice. Both PAHC and PME.AX are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is PAHC better than PME.AX for value investing?

On the Buffett-style value-investing framework, PME.AX currently grades higher — 78/100 vs 43/100, a 35-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between PAHC and PME.AX on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). PAHC currently scores 43/100 (D grade); PME.AX scores 78/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, PAHC or PME.AX?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. PAHC and PME.AX are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, PAHC or PME.AX?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are PAHC and PME.AX both Healthcare stocks?

Yes — both Phibro Animal Health Corporation (PAHC) and Pro Medicus Limited (PME.AX) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this PAHC vs PME.AX comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Phibro Animal Health

PAHC$1.53BHealthcare Market cap, Sector

Pro Medicus Limited

PME.AX$18.96BHealthcare Market cap, Sector

Overall winner

Pro Medicus Limited

PAHC 07 PME.AX

Fit scores by strategy

PAHC0wins

7winsPME.AX

Warren Buffett

43F

B78

Benjamin Graham

76B

A90

Philip Fisher

27F

A98

Peter Lynch

31F

A100

Joel Greenblatt

40F

B84

Charlie Munger

38F

A91

Terry Smith

34F

A96

Side-by-side metrics

Metric	PAHC	PME.AX
Market cap	$1.53B	$18.96B Winner
P/E (TTM)	Winner: 15.5x	147.6x
EV/EBIT	Winner: 20.0x	106.8x
ROIC (TTM)

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

PAHC leads on

P/E (TTM)15.5xvs 147.6x+90%
EV/EBIT20.0xvs 106.8x+81%

PME.AX leads on

EPS CAGR 5y37.34%vs -2.92%+108%
Debt / Equity0.0xvs 2.2x+100%

More like PAHC

PAHC vs CAMX.ST PAHC vs BSLN.SW PAHC vs 1681.HK PAHC vs HALO

More like PME.AX

PME.AX vs CAMX.ST PME.AX vs BSLN.SW

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Industries

Rankings

Glossary

Tools & Methodology

Phibro Animal Health

Pro Medicus Limited

Fit scores by strategy

Side-by-side metrics

Where each one wins

More like PAHC

More like PME.AX

Related on invest-like

Key terms in this analysis